RESOURCE CENTER

Everest Group Report: Redefining Pharma Engagement With AI

Discover how an AI-enabled platform can optimize stakeholder engagement across the value chain.

The Pharma industry is facing a pivotal challenge: while stakeholders like HCPs, KOLs, and patients expect personalized, connected experiences, siloed teams and fragmented data make each touchpoint feel disjointed. This report by Everest Group uncovers a new path forward, revealing how an AI-enabled platform can bridge these gaps to create seamless, end-to-end experiences across the entire value chain, from clinical trials to post-commercialization.

Unlock the future of Pharma engagement with AI

Discover the building blocks, benefits, and ROI of an end-to-end, AI-enabled engagement platform

Get key insights from 75 Pharma executives, including current engagement model pain points, AI adoption readiness, and more
Explore the building blocks and strategic use cases of an end-to-end, AI-enabled engagement platform
Learn about the business benefits and key priorities for AI adoption, including ROI expectations and change management strategies

First name Enter your first name

Last name Enter your last name

Job title Enter your title

Email Enter a valid email address

Phone Enter a valid phone number

Country/Region Select your country

By registering I confirm that I have read and agree to the Privacy Statement.

This field is required.

More Resources

Report

The Transformative Impact of Agentic AI in Life Sciences

Report

Status Quo or Future Leader: The Life Sciences Opportunity

Webinar